Nobuaki Nakagawa

Title: Innovations of Nobuaki Nakagawa

Introduction

Nobuaki Nakagawa is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of biomedical research, particularly in the area of bone disease treatment. With a total of 11 patents to his name, Nakagawa's work has the potential to impact many lives.

Latest Patents

His latest patents include methods for reducing bone absorption through the administration of antibodies that bind to osteoclastogenesis inhibitory factor (OCIF). These patents also cover novel proteins and polypeptides that interact with OCIF-binding molecules (OBMs) and the nucleic acids encoding these proteins. The processes for producing these proteins and nucleic acids through genetic engineering are also detailed in his patents. Additionally, medicinal compounds that comprise these proteins and nucleic acids, as well as anti-OBM antibodies, are provided for the treatment of bone diseases. One of his notable inventions involves a protein that inhibits osteoclast differentiation and maturation, which can be produced by human embryonic lung fibroblasts. This protein has a molecular weight of approximately 60 kD and 120 kD under different conditions and can be isolated from the culture medium of fibroblasts.

Career Highlights

Throughout his career, Nakagawa has worked with notable companies such as Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His experience in these organizations has contributed to his expertise in the field of biomedical innovations.

Collaborations

Some of his coworkers include Masaaki Goto and Eisuke Tsuda, who have collaborated with him on various projects.

Conclusion

Nobuaki Nakagawa's innovative work in the field of bone disease treatment showcases his dedication to advancing medical science. His patents reflect a commitment to improving health outcomes through research and development.